Healthcare procurement startup Aumet raised $12 million in Series A funding as the company looks to expand its artificial intelligence (AI)-powered pharmaceutical supply chain platform across the Gulf Cooperation Council (GCC) region and other emerging markets.
The Saudi-founded company operates a B2B healthcare marketplace and procurement platform connecting pharmacies, distributors, manufacturers and hospitals.
Aumet said in a Wednesday (May 13) press release announcing the round that more than 12,000 pharmacies now operate within its network, with the platform processing more than $1 billion in gross merchandise volume.
The funding comes as healthcare systems across the Middle East accelerate investments in digitizing pharmaceutical supply chains, a sector rife with fragmented procurement workflows, manual inventory tracking and limited real-time visibility into medicine availability.
Aumet’s platform provides an infrastructure layer that drives procurement, inventory and decision-making across the healthcare ecosystem, the company said in the release. Its software ties pharmacies, hospitals, suppliers and healthcare systems into a unified network, offering real-time visibility and AI-driven decision-making across the medical supply chain.
Within the healthcare industry, AI adoption is moving beyond diagnostics and clinical workflows into operational infrastructure, particularly procurement, inventory management and supply chain coordination. Healthcare procurement has historically operated through disconnected distributor relationships, siloed purchasing systems and reactive inventory management, creating inefficiencies that became especially visible during the pandemic and subsequent global supply disruptions.
Advertisement: Scroll to Continue
That shift mirrors a larger trend PYMNTS has been tracking across healthcare and enterprise infrastructure. As PYMNTS previously reported, healthcare providers are increasingly turning to AI and embedded finance tools to improve supplier coordination, automate procurement decisions and strengthen operational resilience as cost pressures rise across the sector.
PYMNTS recently reported that supply chains are beginning to “think and act on their own” as AI models become embedded directly into logistics, inventory management and procurement systems capable of executing decisions in real time rather than simply surfacing recommendations.
Aumet is attempting to build that type of centralized intelligence layer for pharmaceutical procurement across emerging markets, where fragmented supplier ecosystems and inconsistent infrastructure have historically made inventory visibility and purchasing coordination difficult at scale.
Aumet currently operates across Saudi Arabia, Jordan, Egypt and Oman, according to company materials.
